Navigation Links
Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV
Date:10/17/2007

omplementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether the company will successfully enroll 80 matched, related stem cell transplant donor/recipient pairs or 80 additional recipients in a timely manner, if at all; whether the CMV vaccine will achieve the safety and efficacy endpoints in the Phase 2 trial for stem cell transplant donors and/or recipients, including whether the favorable interim safety data are predictive of safety data for the full trial; whether the company will expand development of a CMV vaccine to address prevention of congenital disease; whether the vaccine will induce both antibody and cellular immune responses; whether the vaccine will prevent clinically significant CMV levels; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.

Contacts: Investors: Media:

Alan R. Engbring Susan Neath

Vical Incorporated Porter Novelli Life Sciences

(858) 646-1127 (619) 849-6007

Website:

SOURCE Vical Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for the ... interim chief executive officer Howie Rosen will ... financial officer Tim Morris will be presenting ... two presentations are as follows: Jefferies 2015 ...
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "North American ... Graft), by Application (Surgical Wound, & Ulcer), by ... to 2019" report to their offering. ,     ... care market is estimated to grow at a ...
(Date:5/21/2015)... 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) today ... Watson , the company,s vice president of operations, was granted ... stock, at a per share exercise price of $0.43, the ... was granted pursuant to Cardica, Inc.,s Inducement Plan, which was ... under Rule 5653(c)(4) of the Nasdaq Global Market for equity ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
(Date:5/22/2015)... May 22, 2015 Hands On HealthCare ... 17, 2015, the Annual One Day Sale on ... Hands On HCMT offers drastically reduced certificates one day a ... have enough sessions, through what used to be the slowest ... for the community as well. This once a year occurrence ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Carnegie ... today announced a new partnership to develop BodyTech, ... the region. The initiative includes a new exhibit at ... live demonstration theater, and a new traveling science show, ... fall of 2015. , Designed to explore a ...
(Date:5/22/2015)... According to a new Aegis Living Study on ... likely to worry about what will happen to their memory ... 69% Silent Generation), which may help explain why nearly half ... particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). The ... among more than 2,000 U.S. adults ages 18+. , ...
(Date:5/22/2015)... 2015 ZH Healthcare ... announced today that Bill Lane, joins ZH’s Advisory ... of BlueEHS,a first of its kind, Freemium SaaS, ... Electronic Health Records (EHR) with an integrated practice ... comprehensive patient portal, and more. Combined with its ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Gateway Building ... exterior renovations. The services the company specialize in include ... remodeling, basements, pool houses and much more. , ... by the owner of the company. It includes two ... The design was thought out to be used with ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2
... could help explain how multiple sclerosis (MS) and other autoimmune ... MS is an autoimmune disease of the central nervous ... The research, directed by Dr Bruno Gran at The ... the immune system known as regulatory T cells, which control ...
... Maureen Salamon HealthDay Reporter , THURSDAY, Feb. ... for just appliances anymore. In a new small study, ... that releases bone-building drugs at the push of a ... for various health conditions. Roughly 1.5-by-2.5 inches in ...
... and Julio Montaner of the British Columbia Centre for ... Essay published in this week,s PLoS Medicine that the ... because economic analyses have not yet taken into account ... transmission. The authors comment: "the strategic value ...
... have a demanding job, and lately it,s becoming even tougher. ... Florida educators rely on a free, online system built at ... resources, just when they need them. Soon thanks to ... using federal Race to the Top funds that system ...
... Feb. 16 (HealthDay News) -- Teens victims of dating violence ... as sexual violence and child abuse, according to a new ... aged 12 to 17 revealed that every victim of dating ... victimized, the researchers at the University of New Hampshire Crimes ...
... February 16, 2012 -- Soldiers in the National Guard ... risk of developing alcohol-related problems during and after deployment, ... and Alcohol Dependence journal. Researchers at Columbia University,s ... other institutions found that the soldiers at greatest risk ...
Cached Medicine News:Health News:The balancing act between protection and inflammation in MS 2Health News:Implanted Microchip Might Be Future of Drug Delivery 2Health News:Implanted Microchip Might Be Future of Drug Delivery 3Health News:$10.5 million grant will expand vast online hub for educators, by educators 2Health News:$10.5 million grant will expand vast online hub for educators, by educators 3Health News:$10.5 million grant will expand vast online hub for educators, by educators 4Health News:Teens Victimized by Dating Violence Often Have Difficult Pasts 2Health News:National guardsmen face a high risk of developing alcohol abuse problems following deployment 2
Hardy pituitary spoon, bayonet, malleable....
Cushing pituitary spoons, malleable copper, silver plated....
... on the T.L.I.F. market as the premium banana-shaped ... clinical history and the amazing success of the ... sure to be king of the jungle amongst ... mm in height. The footprint is 28 mm ...
... Implant system. Material that has a modulus ... The result is an implant that meets ... while optimizing the fusion environment through an ... design with 5 and 10 degrees of ...
Medicine Products: